The laboratory of Dr. Toshifumi Yokota invites applications for postdoctoral and graduate student positions in the Department of Medical Genetics at the University of Alberta. By utilizing integrative experimental and computational approaches, such as antisense oligonucleotides and CRISPR/Cas9, the focuses of our group are to develop novel molecular therapies for neuromuscular diseases and rare genetic diseases. Our group is actively collaborating with the world-class researchers and industry partners.
The highly interdisciplinary and collaborative environment of our research group provides unique career development opportunities for the postdoctoral trainees and graduate students. The program is run by Dr. Toshifumi Yokota, Assistant Professor and the Muscular Dystrophy Canada Research Chair. His laboratory is renowned internationally for its work on the development of exon skipping/antisense technology as well as the study on animal models. The CIHR Program will focus on advancing novel therapies for genetic diseases.
Postdoctoral Fellows: Applicants should have a Ph.D. degree (or equivalent) in biomedical sciences. Strong background in one or more of the following areas i) RNA biochemistry, ii) neurology, iii) molecular biology, iv) muscle biology, and v) mammalian cell biology. Mouse model experience is not required, but highly desirable. In order to qualify as a postdoc, the individual must be within 5 years of receiving their Ph.D. All applicants should have good spoken and written communication skills in English.